ATE264683T1 - Verfahren zur herstellung wasserdispergierbare sterol formulierungen - Google Patents

Verfahren zur herstellung wasserdispergierbare sterol formulierungen

Info

Publication number
ATE264683T1
ATE264683T1 AT99301209T AT99301209T ATE264683T1 AT E264683 T1 ATE264683 T1 AT E264683T1 AT 99301209 T AT99301209 T AT 99301209T AT 99301209 T AT99301209 T AT 99301209T AT E264683 T1 ATE264683 T1 AT E264683T1
Authority
AT
Austria
Prior art keywords
disppersible
producing water
sterol
sterol formulations
sitosterol
Prior art date
Application number
AT99301209T
Other languages
German (de)
English (en)
Inventor
Brid Burruano
Michael R Hoy
Richard D Bruce
John D Higgins
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/025,952 external-priority patent/US6110502A/en
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of ATE264683T1 publication Critical patent/ATE264683T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99301209T 1998-02-19 1999-02-18 Verfahren zur herstellung wasserdispergierbare sterol formulierungen ATE264683T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/025,952 US6110502A (en) 1998-02-19 1998-02-19 Method for producing water dispersible sterol formulations
US09/185,788 US6054144A (en) 1998-02-19 1998-11-04 Method for producing water dispersible sterol formulations

Publications (1)

Publication Number Publication Date
ATE264683T1 true ATE264683T1 (de) 2004-05-15

Family

ID=26700515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99301209T ATE264683T1 (de) 1998-02-19 1999-02-18 Verfahren zur herstellung wasserdispergierbare sterol formulierungen

Country Status (16)

Country Link
EP (1) EP0947197B1 (enExample)
JP (1) JPH11313644A (enExample)
CN (1) CN1161123C (enExample)
AT (1) ATE264683T1 (enExample)
AU (1) AU760314B2 (enExample)
BR (1) BR9902325A (enExample)
CZ (1) CZ298506B6 (enExample)
DE (1) DE69916522T2 (enExample)
DK (1) DK0947197T3 (enExample)
ES (1) ES2216439T3 (enExample)
HU (1) HUP9900434A2 (enExample)
IN (1) IN185730B (enExample)
NO (1) NO990747L (enExample)
NZ (1) NZ334189A (enExample)
PL (1) PL192906B1 (enExample)
PT (1) PT947197E (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE512958C2 (sv) * 1998-04-30 2000-06-12 Triple Crown Ab Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
US6123978A (en) 1998-08-31 2000-09-26 Mcneil-Ppc, Inc. Stable salad dressings
US6376481B2 (en) 1998-09-02 2002-04-23 Mcneil-Ppc, Inc. Sterol esters in tableted solid dosage forms
US6677327B1 (en) * 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions
GB0021498D0 (en) * 2000-09-01 2000-10-18 Novartis Nutrition Ag New formulation
AU2005234649B2 (en) * 2000-09-01 2008-01-17 Forbes Medi-Tech, Inc. Water-dispersible encapsulated sterols
KR20020026053A (ko) 2000-09-30 2002-04-06 노승권 음료용 식물성 스테롤의 분산방법 및 이를 함유하는 음료
GB0104074D0 (en) * 2001-02-19 2001-04-04 Novartis Ag New composition
US20030003131A1 (en) * 2001-06-22 2003-01-02 Matthew Dyer Method for manufacture of free-flowing powder containing water-dispersible sterols
EP1420779B1 (en) 2001-07-24 2012-01-18 Cargill, Incorporated Process for isolating phenolic compounds
AU2002241369B2 (en) * 2002-03-20 2009-05-28 Eugene Science Inc. Mixing powder of plant sterol and emulsifier, and method for preparing the same
US6623780B1 (en) 2002-03-26 2003-09-23 Cargill, Inc. Aqueous dispersible sterol product
EP1499206A1 (en) * 2002-04-10 2005-01-26 Thomas P. Binder Hydrothermically processed compositions containing phytosterols
EP1549159B1 (en) 2002-06-12 2008-11-12 The Coca-Cola Company Beverages containing plant sterols
US7306819B2 (en) 2002-06-12 2007-12-11 The Coca-Cola Company Beverages containing plant sterols
US7732000B2 (en) * 2002-06-20 2010-06-08 General Mills, Inc. Food intermediate having sequestered phytosteryl esters in a polysaccharide matrix
US20060035009A1 (en) * 2004-08-10 2006-02-16 Kraft Foods Holdings, Inc. Compositions and processes for water-dispersible phytosterols and phytostanols
WO2006074752A1 (en) * 2005-01-14 2006-07-20 Unilever N.V. Sachets comprising plant sterol
DE102005008445A1 (de) 2005-02-24 2006-08-31 Cognis Ip Management Gmbh Zuckerhaltige Sterolfeststoffdispersionen
DE102005039835A1 (de) * 2005-08-23 2007-03-01 Cognis Ip Management Gmbh Pulverförmige Sterolformulierungen mit Kolloidbildnern
CN111529500B (zh) * 2020-06-28 2021-09-24 江西谷物源食品有限公司 一种提高谷维素溶解度的药物组合物及其制备方法
CN112618665B (zh) * 2020-12-19 2022-06-14 杭州益品新五丰药业有限公司 一种提高免疫反应的糠甾醇-谷维素联合用药制剂
CN118252251A (zh) * 2022-12-28 2024-06-28 丰益(上海)生物技术研发中心有限公司 含植物甾醇酯的组合物及其制备方法及食品

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
US4195084A (en) * 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
DE3829643A1 (de) * 1988-09-01 1990-03-15 Roecar Holdings Nv Phyto- und zoosterole und deren derivate mit verbesserter wasserloeslichkeit
US5270041A (en) * 1989-07-21 1993-12-14 Marigen S.A. Sterols, their fatty acid esters and glucosides; processes for their preparation; spontaneously dispersible agents containing these compounds, and their use for treatment of tumors
CH681153A5 (de) * 1991-01-28 1993-01-29 Marigen S.A. Neue sterolester- und sterolphosphorverbindungen.
AU664827B2 (en) * 1991-05-03 1995-12-07 Raisio Benecol Ltd. A substance for lowering high cholesterol level in serum and a method for preparing the same

Also Published As

Publication number Publication date
NO990747L (no) 1999-08-20
DE69916522D1 (de) 2004-05-27
EP0947197A1 (en) 1999-10-06
CN1161123C (zh) 2004-08-11
AU760314B2 (en) 2003-05-15
DK0947197T3 (da) 2004-07-26
IN185730B (enExample) 2001-04-14
HU9900434D0 (en) 1999-04-28
JPH11313644A (ja) 1999-11-16
CZ54799A3 (cs) 1999-09-15
NZ334189A (en) 1999-07-29
PL331546A1 (en) 1999-08-30
PL192906B1 (pl) 2006-12-29
CZ298506B6 (cs) 2007-10-24
PT947197E (pt) 2004-08-31
HUP9900434A2 (hu) 2001-06-28
DE69916522T2 (de) 2005-07-21
EP0947197B1 (en) 2004-04-21
AU1735899A (en) 2000-06-08
NO990747D0 (no) 1999-02-18
CN1232668A (zh) 1999-10-27
BR9902325A (pt) 2000-04-11
ES2216439T3 (es) 2004-10-16

Similar Documents

Publication Publication Date Title
DE69916522D1 (de) Verfahren zur Herstellung wasserdispergierbare Sterol Formulierungen
EP1298194A3 (en) Stanol comprising compositions
MY130498A (en) Corandomized fat compositions for infant formulas
EE200000498A (et) Meetod ß-sitosterooli või ß-sitosterooli ja ß-sitostanooli rasvasegu valmistamiseks, rasvasegu, selle kasutamine, ning meetod ß-sitosterooli või ß-sitosterooli ja ß-sitostanooli lisamiseks toiduainetesse
AR022541A1 (es) Composiciones de fitoesterol y fitoestanol
DE69929411D1 (de) Verfahren zur Herstellung dispergierbarer Sterol- und Stanolverbindungen
FI934869A7 (fi) Menetelmä seerumin korkean kolesterolitason alentamiseen käytettävän aineen valmistamiseksi
DE69429873D1 (de) Teilchenförmige aromazusammenstellungen und verfahren zur herstellung derselben
DE60128572D1 (de) Verfahren zur Herstellung von Milchpulver und konzentrierten Milchprodukten
DE60132771D1 (de) Verfahren zur herstellung von cyclopropylcarbonsäureestern und deren derivaten
DE60008157D1 (de) Verfahren zur Herstellung von härtbaren Zusammensetzungen und Zusammensetzungen daraus
DE60141424D1 (de) Verfahren zur Herstellung von Dihydroxyestern und ihren Derivaten
DE60036374D1 (de) Pflanzliche sterol-enthaltende fettzusamensetzungen sowie verfahren zur herstellung derselben
ATE349425T1 (de) Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
HUP9800120A3 (en) Pharmaceutical compositions of neutral taste containing quinolon derivatives as active components and process for producing them
ATE221772T1 (de) Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt
BR9505246B1 (pt) composiÇço de material de Ácido de fermentaÇço de fosfato de monocÁlcio e mistura para cozimento para preparo de massa comestÍvel cozida.
DE69713040D1 (de) Verfahren zur Herstellung von Cyclopropylacetylen und dessen Derivaten
DE69418364D1 (de) Verfahren zur Herstellung von Polybutadienzusammensetzungen
DE60117876D1 (de) Verfahren und esterderivate zur herstellung von cephalosphorinen
DE60105734D1 (de) Verfahren zur Herstellung von 4-Cyano-4-Oxobuttersäureester und 4-Cyano-3-Hydroxybuttersäureester
DE59509258D1 (de) Verfahren zur Herstellung von 3-Halogen- bzw. -Pseudohalogen-alkylsilanestern
ATE245911T1 (de) Schaumspeise und verfahren zu ihrer herstellung, vormischung dafür, und verfahren zur herstellung von dieser vormischung
DE69718437D1 (de) Verfahren zur Herstellung von Calcium (-)-Erythrohydroxyzitrat
MX9605521A (es) Composiciones de grasas coaleatorizadas para formulas infantiles.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0947197

Country of ref document: EP